30% trade margin cap approved for non-scheduled anti-cancer drugs

National Pharmaceutical Pricing Authority (NPPA), the authority responsible for controlling the prices of medicines in India has approved a cap on sale margins for non-scheduled anti-cancer drugs. Non-scheduled anti-cancer drugs are cancer medicines whose prices are not fixed directly by the government, allowing companies to set their own retail rates. This measure is intended to reduce medicine prices and improve affordability. Directorate General of Health Services, the technical advisory body under India's Ministry of Health will finalise the medicines covered, following which NPPA will decide and issue the notification.

Join our 1500+ subscribers to get our daily Health Laws and Policy Updates.